UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM N-PX
ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED
MANAGEMENT INVESTMENT COMPANY
Investment Company Act file number: 811-21527
THE ENDOWMENT MASTER FUND, L.P.
(Exact name of registrant as specified in charter)
4265 SAN FELIPE, SUITE 800
HOUSTON, TEXAS 77027
(Address of principal executive offices) (Zip code)
George Zornada, Esq.
K&L Gates
State Street Financial Center
One Lincoln Street
Boston, MA 02111
(Name and address of agent for service)
Registrant’s telephone number, including area code: (713) 993-4675
Date of fiscal year end: December 31
Date of reporting period: July 1, 2012 through June 30, 2013
Form N-PX is to be used by a registered management investment company, other than a small business investment company registered on Form N-5 (§§ 239.24 and 274.5 of this chapter), to file reports with the Commission, not later than August 31 of each year, containing the registrant’s proxy voting record for the most recent twelve-month period ended June 30, pursuant to section 30 of the Investment Company Act of 1940 and rule 30b1-4 thereunder (17 CFR 270.30b1-4). The Commission may use the information provided on Form N-PX in its regulatory, disclosure review, inspection, and policymaking roles.
A registrant is required to disclose the information specified by Form N-PX, and the Commission will make this information public. A registrant is not required to respond to the collection of information contained in Form N-PX unless the Form displays a currently valid Office of Management and Budget (“OMB”) control number. Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for reducing the burden to the Secretary, Securities and Exchange Commission, 450 Fifth Street, NW, Washington, DC 20549-0609. The OMB has reviewed this collection of information under the clearance requirements of 44 U.S.C. § 3507.
PROXY VOTING RECORD
FOR PERIOD JULY 1, 2012 TO JUNE 30, 2013
Investment Company Report
| Meeting Date Range: 01-Jul-2012 - 30-Jun-2013 | Report Date: | 01-Aug-2013 | ||||
| Page 1 of 1 | ||||||
The Endowment Master Fund
| PACIRA PHARMACEUTICALS, INC. | ||||
Security: | 695127100 | Agenda Number: 933810269 | ||
Ticker: | PCRX | Meeting Type: Annual | ||
ISIN: | US6951271005 | Meeting Date: 11-Jun-13 | ||
Prop. # | Proposal | Proposed by | Proposal Vote | For/Against Management’s Recommendation | ||||
| 1 | DIRECTOR | |||||||
| 1 PAUL HASTINGS | Mgmt | For | For | |||||
| 2 JOHN LONGENECKER | Mgmt | For | For | |||||
| 3 ANDREAS WICKI | Mgmt | For | For | |||||
| 2 | RATIFICATION OF THE APPOINTMENT OF COHNREZNICK LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2013. | Mgmt | For | For | ||||
| 3 | AN ADVISORY VOTE TO APPROVE THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THE PROXY STATEMENT. | Mgmt | For | For | ||||
| 4 | AN ADVISORY VOTE ON THE FREQUENCY OF FUTURE ADVISORY VOTES TO APPROVE THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. | Mgmt | 1 Year | For | ||||
SIGNATURES
Pursuant to the requirements of the Investment Company Act of 1940, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Registrant: The Endowment Master Fund, L.P.
| By: | /s/ John A. Blaisdell | |
| John A. Blaisdell | ||
| Co-Principal Executive Officer |
Date: August 13, 2013